VIA
ALT icon

Virtus Investment Advisers’s Altimmune ALT Stock Holding History

Virtus Investment Advisers’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$381K Buy
125,363
+73,620
+142% +$220K 0.09% 312
2026
Q1 		$159K Buy
51,743
+1,261
+2% +$5.35K 0.04% 440
2025
Q4 		$182K Buy
50,482
+34,568
+217% +$151K 0.05% 370
2025
Q3 		$60K Buy
15,914
+2,763
+21% +$10.7K 0.02% 436
2025
Q2 		$50.9K Sell
13,151
-5,965
-31% -$32.3K 0.02% 439
2025
Q1 		$95.6K Buy
+19,116
New +$121K 0.03% 427

Other funds holding ALT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Virtus Investment Advisers's ALT Position: Q2 2026 in Review

Virtus Investment Advisers increased its Altimmune (ALT) stake by 142% in Q2 2026, buying an estimated $220K and bringing the position to 125,363 shares worth $381K. The position accounts for 0.09% of the portfolio, ranked #312.

Virtus Investment Advisers first reported a position in ALT in Q1 2025 and has held it in 6 quarters since. 210 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • Virtus Investment Advisers held 125,363 shares of Altimmune worth $381K as of Q2 2026.
  • Virtus Investment Advisers bought 73,620 Altimmune shares in Q2 2026, an estimated $220K.
  • Altimmune made up 0.09% of Virtus Investment Advisers's portfolio in Q2 2026, its #312 holding.
  • Virtus Investment Advisers first reported a position in Altimmune in Q1 2025 and has held it in 6 quarters since.
  • 210 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on Virtus Investment Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.